Tata India Pharma & Healthcare Fund-Direct Plan-Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 38.0577 ↓ -0.64%
[as on 1 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth and its peers as on 1 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 7.74% -0.64% -3.56% -4.29% -0.15% 7.91% 18.26% 14.01% 22.26% 14.7%
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -12.49% -1.3% -3.53% -6.07% -7.61% -12.86% 4.04% 10.56% 14% 13.47%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -8.41% -0.51% -2.15% -6.2% -4.8% -4.64% 7.63% 7.46% 11.9% 11.24%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 20.71% -0.29% -3.55% -3.34% 2.86% 20.19% 22.83% 17.78% 26.13% 14.6%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -2.81% -1% -2.42% -3.71% -6.43% 0.48% 11.75% 15.13% 18.63% 15.01%
SBI COMMA Fund - DIRECT PLAN - Growth 2.08% -1.4% -3.17% -5.11% -1.39% 7.79% 14.04% 9.74% 18.44% 14.92%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -12.74% 5.85% -0.68% 7.04% 67.87% 19.94% -6.85% 39.53% 42.49% -3.93%

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -1.64% -5.6% 4.93% -6.3% 6.93% 3.25% 4.52% 4.39% 0.65% -3.67%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 14.23% 3.14%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.49% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.51%

Equity

NameSymbol / ISINSectorWeight %Other links
SUN PHARMACEUTICAL INDUSTRIES LTDSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology8.43%
HEALTHCARE GLOBAL ENTERPRISES LTDHCG (INE075I01017)Healthcare Services6.30%
DIVI LABORATORIES LTDDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology5.65%
ABBOTT INDIA LTDABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology5.44%
RAINBOW CHILDRENS MEDICARE LTDRAINBOW (INE961O01016)Healthcare Services4.47%
APOLLO HOSPITALS ENTERPRISE LTDAPOLLOHOSP (INE437A01024)Healthcare Services4.32%
CIPLA LTDCIPLA (INE059A01026)Pharmaceuticals & Biotechnology4.27%
DR REDDYS LABORATORIES LTDDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.21%
MAX HEALTHCARE INSTITUTE LTDMAXHEALTH (INE027H01010)Healthcare Services3.80%
FORTIS HEALTHCARE LTDFORTIS (INE061F01013)Healthcare Services3.30%
LUPIN LTDLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.26%
SYNGENE INTERNATIONAL LTDSYNGENE (INE398R01022)Healthcare Services3.02%
BAYER CROPSCIENCE LTDBAYERCROP (INE462A01022)Fertilizers & Agrochemicals3.01%
PFIZER LTDPFIZER (INE182A01018)Pharmaceuticals & Biotechnology2.92%
MANKIND PHARMA LTDMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.91%
GLAXOSMITHKLINE PHARMACEUTICALS LTDGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.72%
PROCTER & GAMBLE HEALTH LTDPGHL (INE199A01012)Pharmaceuticals & Biotechnology2.51%
SAI LIFE SCIENCES LTDSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.41%
ALKEM LABORATORIES LTDALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.35%
ANTHEM BIOSCIENCES LTDANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology2.14%
FDC LTDFDC (INE258B01022)Pharmaceuticals & Biotechnology2.10%
GLOBAL HEALTH LTDMEDANTA (INE474Q01031)Healthcare Services1.68%
DR. LAL PATH LABS LTDLALPATHLAB (INE600L01024)Healthcare Services1.66%
ASTER DM QUALITY CARE LTDASTERDM (INE914M01019)Healthcare Services1.59%
SUMITOMO CHEMICAL INDIA LTDSUMICHEM (INE258G01013)Fertilizers & Agrochemicals1.59%
AJANTA PHARMA LTDAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.57%
ACUTAAS CHEMICALS LTDACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology1.48%
MANIPAL HEALTH ENTERPRISES LTD (INE459N01021)Healthcare Services1.24%
METROPOLIS HEALTHCARE LTDMETROPOLIS (INE112L01020)Healthcare Services1.11%
GILLETTE INDIA LTDGILLETTE (INE322A01010)Personal Products1.09%
BIOCON LTDBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.99%
PI INDUSTRIES LTDPIIND (INE603J01030)Fertilizers & Agrochemicals0.95%
IPCA LABORATORIES LTDIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology0.90%
MOLBIO DIAGNOSTICS LTD (INE869T01028)Healthcare Services0.87%
DR. AGARWALS HEALTH CARE LTDAGARWALEYE (INE943P01029)Healthcare Services0.71%
SYMBIOTEC PHARMALAB LTD (INE899I01028)Pharmaceuticals & Biotechnology0.64%
SANOFI CONSUMER HEALTHCARE INDIA LTDSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology0.52%
HDFC LIFE INSURANCE CO. LTDHDFCLIFE (INE795G01014)Insurance0.50%
ZIM LABORATORIES LTDZIMLAB (INE518E01015)Pharmaceuticals & Biotechnology0.49%
JUBILANT PHARMOVA LTDJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology0.25%
TORRENT PHARMACEUTICALS LTDTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology0.12%

Debt

NameIsinRatingWeight %Yield
Portfolio data is as on date 31 August, 2026

NAV history

Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history

DateNAV% change
1 October, 202638.0577 -0.64%
30 September, 202638.3028 -2.03%
29 September, 202639.0961 0.37%
28 September, 202638.9502 -0.79%
25 September, 202639.2610 -0.52%
24 September, 202639.4643 -0.55%
23 September, 202639.6834 0.38%
22 September, 202639.5349 -0.31%
21 September, 202639.6566 0.39%
18 September, 202639.5025 0.79%
17 September, 202639.1925 0.96%
16 September, 202638.8188 -0.19%
15 September, 202638.8928 -0.89%
11 September, 202639.2439 -0.54%
10 September, 202639.4588 -0.26%
9 September, 202639.5623 0.08%
8 September, 202639.5299 -0.04%
7 September, 202639.5473 0.09%
4 September, 202639.5136 -0.49%
3 September, 202639.7071 0.05%
2 September, 202639.6889 -0.18%
1 September, 202639.7621 -0.71%
31 August, 202640.0470 0.29%
28 August, 202639.9296 -0.21%
27 August, 202640.0126 0.03%
26 August, 202639.9990 0.12%
25 August, 202639.9515 0.59%
24 August, 202639.7181 -0.05%
21 August, 202639.7376 -0.12%
20 August, 202639.7847

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 38.0577 as on 1 October, 2026.
  • What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 7.74% as on 1 October, 2026.
  • What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 7.91% as on 1 October, 2026.
  • What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 18.26% as on 1 October, 2026.
  • What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 14.01% as on 1 October, 2026.
  • What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 14.01% as on 1 October, 2026.
  • What are top 10 holdings of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    Top 10 holdings of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are:
    • SUN PHARMACEUTICAL INDUSTRIES LTD
    • HEALTHCARE GLOBAL ENTERPRISES LTD
    • DIVI LABORATORIES LTD
    • ABBOTT INDIA LTD
    • RAINBOW CHILDRENS MEDICARE LTD
    • APOLLO HOSPITALS ENTERPRISE LTD
    • CIPLA LTD
    • DR REDDYS LABORATORIES LTD
    • MAX HEALTHCARE INSTITUTE LTD
    • FORTIS HEALTHCARE LTD
    • LUPIN LTD
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
    Tata India Pharma & Healthcare Fund-Direct Plan-Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.